Company News
Deutsche Bank Cuts Novo Nordisk Target 9%
Deutsche Bank downgraded Novo Nordisk to Sell from Hold and reduced its price target by 9% to 265 Danish crowns.
The downgrade followed mixed Q2 earnings, a Wegovy sales miss (3.22bn vs 3.3bn crowns)
